Transcript Highlights:

• And genomics in mind, SB315 presents a simple solution by guaranteeing that no citizens' DNA can be modified
• Texans with cancer to access clinical trials that are often multi-state and require access to their genomic
• The threats of undue foreign influence have raised great concerns about protecting our genomic data.

Bills: SB315, SB584, SB1228, SB1484, SB1860, SB1802

Keywords: DNA privacy, genetic privacy, genetic testing, genetic material, DNA ownership, property right in DNA, genetic consent, biological sample, genomics, genetic data, HIPAA, health information privacy, health care provider, research ethics, human subjects research, law enforcement DNA, forensic DNA, paternity testing, medical examiner, genetic discrimination

Transcript Highlights:

• In the pilot, 55 babies had rapid whole genome sequencing performed.
• Genomics has the potential to truly transform medicine.
• whole genome sequencing beyond the NICU should be a priority.
• We did whole rapid genome sequencing.
• We are in full agreement, and we're big fans of rapid whole genome sequencing, indeed of whole genome

Summary: The subcommittee held its first meeting of the 2025-2026 term, took attendance, confirmed a quorum, and heard introductory remarks from members and staff. Chair Anderson outlined the subcommittee’s jurisdiction over access and affordability issues, including health facility regulation, insurance, Medicaid, CHIP, and state employee health coverage. The main agenda item was an update on implementation of HB 391, which created a family home health aide program for medically fragile children. Representative Tramont, the bill sponsor, explained that the law was intended to let trained family caregivers be paid through Medicaid to care for their children, reduce reliance on private duty nursing, and relieve families. He and several members expressed frustration that implementation had taken nearly two years and that families still faced barriers. Deputy Secretary Brian Meyer of AHCA and Bridget Royce of DCF said the program was implemented October 1, 2024, with billing available, but no home health agencies had yet launched the required 80-hour training program and no claims had been paid. They described the program’s requirements, including agency employment, background screening, training, a $25-per-hour Medicaid rate paid to the agency, and an annual assessment report. A major issue discussed was that income earned by family caregivers counts toward Medicaid eligibility and could cause families to lose coverage. AHCA and DCF outlined two possible fixes that would require CMS approval: disregarding the income for eligibility purposes or treating the child as a family of one. Members and public witnesses strongly urged changes to avoid forcing families to choose between income and coverage. Several providers said they had begun preparing training programs, but asked for clearer approval processes and more patient-specific training requirements. The committee then heard extensive public testimony from parents and caregivers of medically fragile children, who described the financial, emotional, and logistical strain of caring for children with severe disabilities and argued that the bill should be expanded to include Florida KidCare families and others in the coverage gap. They also raised concerns about the eight-hour-per-day limit, low pay, and the need for simpler rules and direct support. Home health providers and associations supported the concept but asked for modifications, including more targeted training and clearer implementation guidance. The meeting then shifted to a second agenda item on the Andrew John Anderson Rapid Whole Genome Sequencing Program, which was funded in the 2023 budget. Deputy Secretary Meyer said the program has been implemented since January 1, 2024, but utilization has been lower than expected, with only about 60 claims paid and many denials occurring through managed care. Public testimony from a lab, a hospital, and a pediatric rare disease expert said the program is clinically valuable and cost-saving, but managed care billing barriers, prior authorization issues, and DRG-related denials are limiting access; they urged direct billing to Medicaid and possible expansion to all newborns.

Transcript Highlights:

• The next panel is for an act to provide rapid whole genome sequencing, and the panel is Tom DeFay, Dr
• Ultimately, using rapid whole genome sequencing as a first-line test resulted in substantial net cost
• What's the general cost of rapid genome sequencing? Rapid genome sequencing.
• I'm here to testify in strong support of an act to provide rapid whole genome sequencing.
• We actually had to come to Boston Children's to get a whole genome sequence for him.

Keywords: 995, all

Summary: The Joint Committee on Health Care Financing held a public hearing on a large docket of bills focused on MassHealth benefits and reimbursement, health equity, behavioral health, public health, dental access, 340B drug pricing, tobacco cessation, and coverage for children. The chairs emphasized rising health care costs, provider shortages, administrative burdens, and persistent inequities by income, race, geography, and immigration status. Much of the testimony centered on H.1416/S.901, an act to advance health equity, with legislators and members of the Health Equity Compact arguing for statewide benchmarks, stronger health equity leadership, reimbursement for interpreter services, community health workers and patient navigation, Medicaid graduate medical education support, and a health equity zone trust fund. Witnesses described disparities in life expectancy, maternal mortality, access to primary care, and the impact of federal Medicaid and social service cuts, and urged the committee to report the bill favorably. The committee also heard strong support for H.1368/S.847 on rapid whole genome sequencing for critically ill MassHealth children. Testifiers from industry, academia, hospitals, and families said early sequencing can end long diagnostic odysseys, improve treatment decisions, shorten hospital stays, and save money, while also providing emotional relief and information for families. The hearing then moved to H.1407 on MassHealth rate parity for inpatient behavioral health providers, where Rep. Scanlan and the Massachusetts Association of Behavioral Health Systems said the bill would codify existing administrative parity so managed care plans cannot pay less than the MassHealth fee-for-service rate. On H.1392/S.853 to preserve and protect public health, witnesses supported higher vaccine administration fees to improve provider participation and immunization rates. The committee also heard testimony on H.770/845 to protect 340B providers in MassHealth, and on S.848 to require reporting and transparency around 340B revenues and outside administrative costs. Additional bills drew testimony on tobacco cessation coverage for MassHealth members, with advocates supporting broader access to counseling and medications through medical, behavioral health, and dental providers. On H.1409, a nursing home operator asked for more flexibility in a MassHealth staffing-related penalty tied to patient days per resident. On H.1401/S.888, supporters of the “Take 10” dental access proposal said adult MassHealth dental coverage is underused because too few dentists accept MassHealth, leading to long travel times and avoidable emergency room visits; they urged incentive payments for dentists serving new adult MassHealth patients. Finally, on H.1403/S.855, “Cover All Kids,” advocates and immigrant community members urged removal of immigration status as a barrier to full MassHealth coverage for children, while also backing a related bill to ensure 12 months of continuous coverage for children. No votes were taken during the hearing; the committee primarily received testimony and asked questions on costs, reimbursement levels, and implementation details.

Transcript Highlights:

• Ryan Anderson, Rapid whole genome sequencing program.
• The and Regina Anderson, rapid whole genome sequencing program.
• the entire genome of an individual.
• And so what is the genome first?
• It was really just limited to targeted Exome and genome panels.

Transcript Highlights:

• They list three of those, and broad evidence of genome instability with impaired DNA repair.
• instability with impaired DNA of genome instability with impaired DNA repair.<01:26:28.480> Uh,
• These findings highlight an urgent need for systemic genomic surveillance, orthogonal validation with
• instability, contributing to genomic instability, contributing to genomic instability, epigenetic
• <02:07:21.119> In possibility of genomic insertion. In possibility of genomic insertion.

Keywords: 1189, house, all

Summary: The committee met as a special House committee on COVID response efficacy, noted absences, and restated its mission to review New Hampshire’s pandemic response, including federal guidance, federal funds, emergency use authorization vaccination efforts, long COVID treatment, patient bill of rights implementation, and vaccination policies. The main business was discussion of a proposed letter or report language concerning current COVID vaccine recommendations for young children, especially those under age two, and how to support any conclusions with cited scientific and state sources. Representative Polozov argued that the committee should ask the governor or agencies to reconsider current recommendations, saying the committee should focus on whether vaccination is needed for that age group, whether it is effective, and whether the risks outweigh the benefits. He said he had distributed articles and wanted the committee to pair its conclusions with scientific and statistical data. Other members asked him to identify the specific New Hampshire DHHS and American Academy of Pediatrics sources for the recommendation, clarify the age range being discussed, and separate any evidence about adverse effects in other age groups from the infant/toddler demographic so the letter would be transparent and not misleading. Members generally agreed the letter should be carefully sourced and refined, with citations for each claim. The chair said the committee would treat the request as urgent and try to finalize a version by the next meeting, noting that some members would be traveling. The committee also discussed scheduling additional testimony in September and October, possibly with extra meetings, to continue gathering evidence and to hear from witnesses. The chair then began reviewing supporting articles, including studies he said were new since the 2024 report, and introduced a 2025 South Korea cohort study and another 2025 Italian cohort study as examples of the evidence he wanted to incorporate into an updated 2026 report.

Transcript Highlights:

• We had thousands of genome sequences from deer. We also worked on LP.
• So we set about to search the whole genome in these two papers.
• We need to know where the largest effect regions of the genome are.
• So what is this genomic prediction and why does it matter?
• Traits, genomic selection, genomic prediction. Same with aquaculture, right?

Bills: HB3270, HB3145, HB3056

Keywords: farmed cervidae, chronic wasting disease, genetic resistance, wildlife management, agriculture, wildlife tagging, hunting regulations, Cervidae family, feral swine, exotic wildlife, conservation, commercial hunting, raw milk, unpasteurized, farm sales, Oklahoma Milk and Milk Products Act, local producers, advertising, 914, all

Transcript Highlights:

• We want you to read them and to be a resource to you in genomics and biotech and what’s happening in
• We want you to read them and to be a resource to you in genomics and biotech and what’s happening in
• We want you to read them and to be a resource to you in genomics and biotech and what’s happening in
• We want you to read them and to be a resource to you in genomics and biotech and what’s happening in
• <00:32:58.080> and know we we firmly sit in genomics and know we we firmly sit in genomics

Bills: HB187, HB98, HB360, HB394, HB398, HB388, HB187, HB98, HB360, HB394, HB398, HB388

Keywords: school safety, emergency response, training, public safety, Alyssa's Law, law enforcement, scholarship, tuition assistance, dependent education, Alabama, blackout license plate, HB360, Second Amendment Sales Tax Holiday, sales tax holiday, firearms, guns, ammunition, bullets, primers, gun accessories

Transcript Highlights:

• mission area to impact the students, teachers, and communities across Alabama, specifically around genomics
• beads that every year a jar with beads that indicate all the people that we get to impact through genomics
• as have Hudson Alpha and Alabama be seen as that Alpha and have Alabama be seen as that leader in genomics
• say thank you so much for your support and your trust in what we're doing to reach our state in genomics
• book where we, just because we are lifelong learners ourselves, we're constantly reading stories of genomics

Bills: HB447, HB447

Keywords: HB447, school buses, student transportation, public schools, local boards of education, dual enrollment, career technical education, CTE, community college, trade school, technical college, offsite educational venues, student access, transportation policy, school bus law, Alabama education law, Montgomery County, probate court, judge of probate, will registration

Transcript Highlights:

• Research Program at FSU, a pediatric clinic for undiagnosed and complex diseases, a certified whole genome
• sequencing diagnostic laboratory, a viral vector and genome editing facility, a master's degree program
• , and finally, the Sunshine Genetics newborn whole genome sequencing pilot program.
• The Sunshine Genetics Act supports newborn whole genome sequencing across Florida.
• For this program, families volunteer with fully informed consent to have their baby's genome sequenced

Summary: The Health Professions and Program Subcommittee met with a quorum present and received a briefing from Melissa Jordan, Assistant Deputy Secretary for Health and chair of the Florida Rare Disease Advisory Council (ARDAC). Jordan explained that rare diseases affect fewer than 200,000 people each individually, but together impact an estimated 2.3 million Floridians. She reviewed ARDAC’s structure, its three subcommittees, and its 2025 legislative report recommendations, which focused on expanding Florida-specific data, disaster preparedness, state agency coordination, insurance oversight, provider education, faster diagnostic tools, research collaboration, and establishing centers of excellence. She also highlighted ARDAC’s work with other states and its effort to build an online repository of resources for families and providers. Jordan discussed the Andrew John Anderson Pediatric Rare Disease Grant Program, funded at $500,000 annually, which supported research awards at Florida State University and the University of Miami in 2024 and another University of Miami project in 2025. She also described House Bill 907 and the Sunshine Genetics Act pilot program, which created the Florida Institute for Pediatric Rare Diseases at FSU and a newborn whole-genome sequencing pilot to screen volunteer infants for hundreds of conditions beyond traditional newborn screening. The institute will include research, training, clinical care, a diagnostic lab, genome editing capacity, and a sequencing pilot overseen by a board, consortium, and steering committee. Members asked about interstate collaboration, the scope of data collection beyond Medicaid, how the council reduces family financial burdens, how families and providers can learn about available resources, and how ARDAC measures effectiveness. Jordan said Florida has learned from other states’ survey-based approaches and instead is using administrative data sources such as Medicaid, hospitalizations, emergency department visits, birth and death certificates, with more clinical data to be added over time. She said success is tracked through annual reports, ongoing work plans, and quarterly research reports that measure progress, patient enrollment, treatment outcomes, and potential follow-on funding. The meeting concluded after the presentation and questions, and the subcommittee adjourned without further business.

Transcript Highlights:

• This is a measure to protect Texas's genomic information from foreign adversaries that seek to use genomic
• Foreign adversary genomic companies are legally bound to to turn over genomic data they collect to their
• necessary access to genomic data.
• BGI Genomics is, or Beijing Genomics, known as BGI is what is called a national champion biotechnology
• The national champion genomics company.

Bills: HB17, HB34, HB41, HB 118, HB 119, HB 127, HB 128, HB 129, HB 130, HB132, HB133, HB17, HB41, HB118, HB119, HB127, HB128, HB129, HB130, HB132, HB133

Keywords: foreign ownership, real estate, national security, designated countries, Texas property law, lobbying, foreign adversaries, compensation prohibition, transparency, civil penalties, higher education, foreign adversary, research security, trade secrets, academic partnerships, HB 128, sister city, sister-city agreement, international exchange, municipal diplomacy

Transcript Highlights:

• The bill establishes an opt-in newborn screening program to be administered by FSU to offer whole genome
• The bill establishes an opt-in newborn screening program to be administered by FSU to offer whole genome
• Finally, through our universities, this bill will establish Florida as a leader in genomic medicine.
• And it will position Florida as a hub for a $100 billion genomic medicine industry. Mr.
• Florida stands at the forefront of a $100 billion genomic medicine industry by establishing the Sunshine

Summary: The Education Administration Subcommittee heard and approved four bills focused on school safety, student health, and classroom environment. HB 1403, Safety of Students, would expand Guardian program participation to child care facilities, require substitute teachers to receive campus safety protocols, and allow limited exceptions for certain CTE classrooms; it drew supportive testimony from school safety and education groups and passed 16-0. PCS for HB 907, the Sunshine Genetics Act, would create the Florida Institute for Pediatric Rare Diseases at FSU and launch an opt-in newborn whole-genome screening program funded with $20 million; supporters said it could speed diagnosis, save lives, and reduce health care costs, and it passed 17-0. HB 949 would prohibit student use of wireless communication devices during the full school day, while allowing districts flexibility in implementation and medical exceptions; supporters cited distraction and bullying data, and the bill passed 17-0. The committee also approved HB 723, the Type 1 Diabetes Early Detection Program, which requires the Department of Health to provide school-based informational materials to parents and guardians about early warning signs, risk factors, and screening for type 1 diabetes. An amendment broadened the notification to include voluntary pre-K, kindergarten, and first grade and shifted the annual notice to September 30. Testimony in support came from diabetes advocates and pediatric groups, and members spoke about personal experiences with diabetes and the value of earlier education. The bill passed 17-0 after the amendment was adopted. Across the meeting, members from both parties generally praised the bills as bipartisan efforts to improve student safety, health, and learning conditions. Several members raised questions or concerns about implementation details, including school guardian tracking, cell phone pouches and emergency access, and how the diabetes notice would be distributed, but no bill faced opposition in committee. All four measures were reported favorably.

Transcript Highlights:

• It gives Florida a once-in-a-generation opportunity to lead the nation in genomic and precision medicine
• The bill establishes an opt-in newborn screening program to be administered by FSU to offer whole genome
• And finally, through our universities, HB 907 will establish Florida as a leader in genomic medicine.
• We're continuing to screen using genome sequencing, as Representative Anderson mentioned, testing for
• With this bill, Florida can set the gold standard for genomic sequencing.

Summary: The Health and Human Services Committee heard a lengthy agenda of health care and public health bills. The first major item was HB 649, which would remove the paper supervision protocol for certified registered nurse anesthetists (CRNAs) and allow autonomous practice. The sponsor and supporters argued it would improve access, especially in rural areas, address workforce shortages, and reduce costs, while opponents from the medical community raised patient safety concerns and argued it would weaken physician oversight. After extensive testimony and debate, the committee reported the bill favorably by a vote of 18-7. The committee then unanimously advanced several other measures. HB 259, creating a special observance for fentanyl awareness and education, passed 23-0. HB 791, which codifies infant safety devices as an option for surrendering newborns and amends safe-haven law, passed as amended 25-0. HB 355, allowing schools to use FDA-approved emergency opioid antagonists rather than only naloxone, passed 26-0. HB 1119, requiring hospitals with emergency departments to adopt pediatric readiness policies, training, coordination, and assessment requirements, also passed 26-0 after two amendments. HB 431, changing the date for level-two background screening of athletic coaches to July 1, 2026, passed 26-0. Later, the committee approved CS for HB 907, the Florida Institute for Pediatric Rare Diseases or “Sunshine Genetics Act,” which would establish an opt-in newborn genome sequencing program at FSU and a statewide consortium for rare disease research; supporters emphasized earlier diagnosis and cost savings, and the bill passed 25-0. CS for HB 519, aligning state law with federal law on controlled substances for paramedics, passed 25-0. Finally, CS for HB 723, requiring the Department of Health to provide early-detection materials for type 1 diabetes to families of young schoolchildren, passed as amended 26-0. The meeting adjourned after all bills were reported favorably.

Transcript Highlights:

• really, what this does is create a criminal penalty if you were to access and use someone's genetic genome
• Exactly; it's kind of vague on what actual crime you're committing if you steal a genome.
• So we're just saying here that this is a crime if you steal someone's genome.
• only applies to those third-party companies or a person who, without your permission, accesses your genome
• Genome and then duplicates it without your permission or sells it. You offering that amendment?

Bills: SB210, SB176, SB167, SB244, SB218, SB9, SB153, SB9

Keywords: hospital liens, medical billing, government healthcare, insurance claims, patient rights, controlled substances, unlawful distribution, marijuana, violent offense, sentencing guidelines, criminal justice, aggravated theft, employee benefits, retirement funds, criminal penalty, state law, overdose, failure to render aid, public health, Alabama Athletic Commission

Transcript Highlights:

• A significant factor in biotechnology, of course, is access to genomic sequencing data.
• medical and research facilities, as well as companies and non-profit organizations, to ensure Texas genome
• It also prohibits access to genome sequencing data by individuals.
• To get to the point about the military use of genetic information, which is harvested, Beijing Genomics
• regulatory power over health care to prohibit the use of these technologies and the harvesting of genomic

Bills: SB30, SB517, SB1313, SB1314, SB1316, SB1541, SB1698, SB1845, SB1860, SB2420, SB2429, SB 30

Keywords: gambling, criminal offenses, penalties, defense, electronic devices, tobacco advertising, youth protection, public health, criminal offense, retailer regulation, e-cigarettes, nicotine products, health, public safety, regulation, advertising restrictions, health and safety, elections, election audit, county elections

Transcript Highlights:

• which is a partnership medical genomics which is a partnership between<00:34:13.919> the<00:34
• We're investing in platform, regenerative medicine, genomics, and most recently our automation efforts
• We're investing in platform, regenerative medicine, genomics, and most recently our automation efforts
• We're investing in platform, regenerative medicine, genomics, and most recently our automation efforts
• and most recently our medicine genomics and most recently our automation<00:54:00.119> efforts

Keywords: 1187, senate, all

Transcript Highlights:

• Communist Party and the Senate Homeland Security Committee was introduced in 2024 to ban China's largest genomics
• So House Bill 130 makes sure that the genetic information of Texans is secured, in particular, genome
• facilities, as well as companies and non-profit organizations, to make sure that... ...makes his genome
• It prohibits access to genome sequencing data by individuals located outside the U.S. unless authorized
• substitute, upon Senator Hall's wise suggestion, ensures that those companies are not able to sell genomic

Bills: SB82, SB1807, SB2254, HB119, HB130, HB581, HJR98, SB1988, SB 18, SB 34

Keywords: business liability, concealed carry, handgun policy, premises liability, criminal acts, civil liability, business premises, concealed handgun, property liability, property rights, gun regulations, criminal liability, protective order, confidentiality, personal information, court records, victim protection, charitable raffle, nonprofit, wildlife conservation

Transcript Highlights:

• The Minnesota partnership for biotechnology and medical genomics was spawned in 2003.
• so if I may have medical U uh genomics so if I may have the<01:03:36.920> first<01:03:37.160>
• for biotechnology and medical genomics for biotechnology and medical genomics uh<01:06:02.839>
• <01:43:03.719> for biotechnology and medical genomics for biotechnology and medical genomics
• <01:44:23.560> work I turn whether it's the genomics work I turn whether it's the genomics

Keywords: 1183, house

Summary: The House Higher Education Finance and Policy Committee met and approved the minutes from the previous meeting. The chair noted that agency overviews from the Office of Higher Education and other state agencies were not available, so the committee proceeded with University of Minnesota presentations instead. The committee also reviewed posted committee rules. University of Minnesota representatives gave an overview of the university’s research enterprise, describing it as a system of five campuses with a possible expansion to St. Cloud, and highlighting research strengths across campuses in agriculture, energy, natural resources, health, and the Twin Cities flagship campus. They said the university has more than $1.3 billion in annual research expenditures, receives most of its research funding from federal sources, and is ranked highly for both overall research and interdisciplinary research. Examples discussed included the Clinical and Translational Science Institute, the Forever Green initiative, and research tied to sustainable crops, health, and commercialization. Members asked questions about specific research areas, including biodegradable or renewable plastics, wheat research, food dyes, health and environmental toxins, and the market for winter camelina and winter pennycress. University staff said they could follow up with more detailed information and explained that the winter crop work is intended to become market-driven over time, while also improving soil health and creating new revenue streams for farmers. They also clarified that the university’s federal research funding includes money from NIH, NSF, DOE, DOD, and other agencies, and that the “other” funding category includes foundations, subawards, and internal university seed funding. The committee then heard a second University of Minnesota presentation focused on partnerships, commercialization, and workforce development. Testimony highlighted collaborations with industry and government partners such as U.S. Steel, 3M, Medtronic, Cisco, and defense-related industry leaders, as well as programs supporting microelectronics, AI, cybersecurity, and sustainable aviation fuels. No formal votes were taken beyond approving the minutes, and the committee ended the segment by moving on to the next testifier.

Transcript Highlights:

• Florida, a once-in-a-generation opportunity to lead the nation in genomic and precision medicine, and
• The bill establishes an opt-in newborn screening program to offer whole genome sequencing at birth free
• research for these complex diseases, and it will position Florida as a hub for a brand new $100 billion genomic

Summary: The Health Care Budget Subcommittee met and took up four bills. First, CS/HB 633 by Rep. Koster on managing entity reporting and transparency for behavioral health services was amended to clarify reporting requirements and timing, and to address the bill’s fiscal implementation through conferencing. Members and one public speaker supported the measure, emphasizing accountability and better use of state funds. The bill was reported favorably. Next, CS/HB 531 by Rep. Hunschofsky on background screenings was amended with a strike-all that would require ACCA to create a public webpage with screening education, level-two screening standards, and a searchable catalog of positions requiring screening. Because the amendment changed the bill’s relating-to clause, the chair noted it would be temporarily postponed under House Rule 7.11D and returned to the committee later. The committee then heard HB 1089 by Rep. Booth, which adds Duchenne muscular dystrophy to the recommended newborn screening panel, subject to appropriation. A parent testified in strong support, describing the benefits of earlier diagnosis and treatment, and several members spoke in favor. The bill was reported favorably. Finally, CS/HB 907 by Rep. Anderson created the Sunshine Genetics Program, an opt-in newborn whole-genome sequencing program, and established the Florida Institute for Pediatric Rare Diseases at FSU and a Sunshine Genetics Consortium. An amendment made funding contingent on appropriations and added Nicholas Children’s Hospital and Florida International University to the consortium board. After supportive testimony and debate, the bill was also reported favorably. The meeting then adjourned.

Transcript Highlights:

• How genomics will play out over the next few years in terms of informing, um, both treatment but also
• How genomics will play out over the next few years in terms of informing, um, both treatment but also
• How genomics will play out over the next few years in terms of informing, um, both treatment but also
• How genomics will play out over the next few years in terms of informing, um, both treatment but also
• How genomics will play out over the next few years in terms of informing, um, both treatment but also

Keywords: 1187, senate, all

Transcript Highlights:

• We have improved the productivity in genetics and genomics 40% using AI.
• We have improved the productivity in genetics and genomics 40% using AI.
• So with precision medicine and what he mentioned with genetics, genomics, looking at things like...
• So with precision medicine and what he mentioned with genetics, genomics, looking at things like pharmacogenetics

Bills: SB1786

Keywords: artificial intelligence, content verification, provenance data, transparency, digital content, 1182, all

Summary: The committee first heard a presentation from Sonora Quest Laboratories on how the company is using artificial intelligence and innovation in clinical lab work. Testimony emphasized that AI is already being used in digital pathology, cytology, genetics, genomics, predictive analytics, and quality control, with a strong focus on human oversight, validation, and closed, secure systems that keep patient data in-house. Speakers said AI can improve accuracy, speed diagnosis, reduce repeat testing, support precision medicine and pharmacogenomics, and potentially help with rare disease management and drug selection, while also noting the need for governance and safeguards. Members asked questions about accuracy, safeguards, data security, whether AI could reduce repeat specimen collection, expand to other hospital labs, and how AI might affect treatment decisions such as step therapy and pharmacogenomics. The presenters said AI outputs are reviewed by specialists, that the systems are validated and monitored, and that the organization uses a closed ecosystem with no external data sharing. They also discussed future possibilities such as digital twins, earlier cancer detection, and more tailored medication choices, while acknowledging that AI is still developing and must be used carefully. The committee then took up Senate Bill 1786, as amended, which requires covered providers using generative AI to add provenance data to AI-created or significantly modified video, image, or audio content, using methods like watermarking or metadata, with exceptions for minor edits and certain interactive or non-user-generated content. The amendment clarified that identifiable individual information generally cannot be included unless the user opts in, protected trade secrets, and set an effective date of February 1, 2027. After discussion about consumer transparency, scope, and possible legal issues, the committee adopted the amendment and voted 4-2 with one absent to give SB 1786 as amended a do pass recommendation.